Blair and Milburn braced for foundation trust backlash
October 28, 2003NHS
The Government’s controversial plans to introduce foundation hospitals are on a knife-edge ahead of a Commons vote on the reform …
OTC omeprazole to become Glaxo’s next generation Zantac
October 28, 2003Sales and Marketing
GlaxoSmithKline is poised to launch omeprazole, AstraZeneca's former prescription-only blockbuster Losec as part of its leading over the counter Zantac …
Sanofi upgrades expectations for 2003
October 28, 2003Sales and Marketing
Sanofi-Synthelabo has upgraded its full-year share earnings guidance for 2003, despite its plans to spend more on R&D.In the first …
Concerns over expansion of fast track surgery
October 28, 2003Doctors and health unions have expressed their concerns about the effect of new fast track surgery centres on the rest …
GlaxoSmithKline slashes AIDS drug prices
October 28, 2003Sales and Marketing
GlaxoSmithKline has cut prices of its HIV/AIDS drugs for developing countries by nearly half following intense pressure from campaigners and …
International performance keeps BMS afloat
October 28, 2003Sales and Marketing
International sales of several key drugs helped Bristol-Myers Squibb to minimise the effects of continued US generic competition in the …
Government proposes ‘clinical exceptions’ to A&E targets
October 28, 2003The Government is to modify one of its key waiting times targets after sustained protests about its inability to reflect …
Money Syner buy-out to create UK’s biggest healthcare agency
October 28, 2003Global healthcare communications agency Euro RSCG Life has acquired Money Syner Communications to create what it says will be the …
Pfizer spots potential of Organon atypical antipsychotic
October 28, 2003Pfizer is to co-develop and promote a promising new atypical antipsychotic discovered by Dutch pharma company Organon.Under the terms of …
Swiss pharma companies beat expecations
October 28, 2003Switzerland's number one pharmaceutical company Novartis has reported a sharp rise in sales in the first nine months of the …
Atypical anti-psychotics to get diabetes warning in US
October 28, 2003All atypical anti-psychotic drugs are to carry warnings on their US labels about potentially fatal hyperglycaemia side-effects and increased risk …
Job cuts at Merck
October 28, 2003US pharma giant Merck is to make 4,400 redundancies in an effort to stem falling profits, following a 7% drop …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
